Last reviewed · How we verify
Convalescent Plasma from COVID-19 donors — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Convalescent Plasma from COVID-19 donors (Convalescent Plasma from COVID-19 donors) — Fundacion Arturo Lopez Perez.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Convalescent Plasma from COVID-19 donors TARGET | Convalescent Plasma from COVID-19 donors | Fundacion Arturo Lopez Perez | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Convalescent Plasma from COVID-19 donors CI watch — RSS
- Convalescent Plasma from COVID-19 donors CI watch — Atom
- Convalescent Plasma from COVID-19 donors CI watch — JSON
- Convalescent Plasma from COVID-19 donors alone — RSS
Cite this brief
Drug Landscape (2026). Convalescent Plasma from COVID-19 donors — Competitive Intelligence Brief. https://druglandscape.com/ci/convalescent-plasma-from-covid-19-donors. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab